# a Pilot Study of Pramipexole to Treat Extrapyramidal Symptoms Induced by Antipsychotics

> **NCT03430596** · EARLY_PHASE1 · COMPLETED · sponsor: **Shanghai Mental Health Center** · enrollment: 50 (actual)

## Conditions studied

- Extrapyramidal Syndrome

## Interventions

- **DRUG:** Pramipexole
- **DRUG:** Trihexyphenidyl hydrochloride

## Key facts

- **NCT ID:** NCT03430596
- **Lead sponsor:** Shanghai Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-01
- **Primary completion:** 2021-10-30
- **Final completion:** 2021-12-30
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2022-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03430596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03430596, "a Pilot Study of Pramipexole to Treat Extrapyramidal Symptoms Induced by Antipsychotics". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03430596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*